1. Home
  2. CLPS vs KALA Comparison

CLPS vs KALA Comparison

Compare CLPS & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLPS
  • KALA
  • Stock Information
  • Founded
  • CLPS 2005
  • KALA 2009
  • Country
  • CLPS Hong Kong
  • KALA United States
  • Employees
  • CLPS N/A
  • KALA N/A
  • Industry
  • CLPS Computer Software: Prepackaged Software
  • KALA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLPS Technology
  • KALA Health Care
  • Exchange
  • CLPS Nasdaq
  • KALA Nasdaq
  • Market Cap
  • CLPS 38.4M
  • KALA 31.3M
  • IPO Year
  • CLPS 2018
  • KALA 2017
  • Fundamental
  • Price
  • CLPS $1.12
  • KALA $6.00
  • Analyst Decision
  • CLPS
  • KALA Strong Buy
  • Analyst Count
  • CLPS 0
  • KALA 2
  • Target Price
  • CLPS N/A
  • KALA $15.00
  • AVG Volume (30 Days)
  • CLPS 28.5K
  • KALA 32.7K
  • Earning Date
  • CLPS 10-18-2024
  • KALA 11-12-2024
  • Dividend Yield
  • CLPS 11.71%
  • KALA N/A
  • EPS Growth
  • CLPS N/A
  • KALA N/A
  • EPS
  • CLPS N/A
  • KALA N/A
  • Revenue
  • CLPS $142,812,726.00
  • KALA N/A
  • Revenue This Year
  • CLPS N/A
  • KALA N/A
  • Revenue Next Year
  • CLPS N/A
  • KALA N/A
  • P/E Ratio
  • CLPS N/A
  • KALA N/A
  • Revenue Growth
  • CLPS N/A
  • KALA N/A
  • 52 Week Low
  • CLPS $0.68
  • KALA $4.21
  • 52 Week High
  • CLPS $1.70
  • KALA $9.25
  • Technical
  • Relative Strength Index (RSI)
  • CLPS 46.98
  • KALA 41.23
  • Support Level
  • CLPS $1.05
  • KALA $5.95
  • Resistance Level
  • CLPS $1.15
  • KALA $6.23
  • Average True Range (ATR)
  • CLPS 0.05
  • KALA 0.29
  • MACD
  • CLPS 0.01
  • KALA -0.07
  • Stochastic Oscillator
  • CLPS 68.75
  • KALA 4.81

About CLPS CLPS Incorporation

CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting service, Customized IT solution service, and other. Generating majority of its revenue from the IT consulting service.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: